News

RMIT University-Led Researchers Develop AI-Powered Glaucoma Screening Test With Rapid Results

KUALA LUMPUR, Oct 28 — A new rapid screening test for glaucoma could help advance early detection of the disease, a leading cause of irreversible blindness.

Developed by a research team of engineers and ophthalmologists led by RMIT University in Melbourne, Australia, the test uses infra-red sensors to monitor eye movement and can produce accurate results within seconds.

According to a statement, about 80 million people worldwide have glaucoma, with more than 111 million expected to be living with the disease by 2040.

Currently, glaucoma is diagnosed through a 30-minute eye pressure test delivered by an ophthalmologist. The new AI-powered test takes just 10 seconds to show if there is a risk of glaucoma, making it ideal for use in a national screening programme.

Lead researcher Professor Dinesh Kumar, RMIT, said early detection, diagnosis and treatment could help prevent blindness, so making screening faster and more accessible was critical.

“This research will allow a non-contact, easy-to-use and low-cost test that can perform routinely at general clinics. It could also promote a community-wide screening programme, reaching people who might not otherwise seek treatment until it’s too late,” he added.

The pioneering technology differentiates between glaucoma and healthy eyes by analysing changes in pupil size. In the study, published in IEEE Access, pupils were measured 60 times per second using a low-cost commercial eye tracker.

Under ambient light conditions, patients looked at a computer screen while custom software measured and analysed specific changes in their pupil size. The software then compared the results against existing samples of glaucoma and healthy eyes to determine the risk of glaucoma.

The team is now looking to adapt the technology to work with smartphone cameras instead of the eye tracker used in the study. They are also looking for a commercial partner ahead of a clinical trial planned for 2022.

With further research, the software could also be extended to detect other neurological conditions.

Sources: BERNAMA

Adib Mohd

Recent Posts

Talentbank Crowns Top Universities in Career Edge Challenge

The inaugural Talentbank Boardroom Challenge has crowned its first champions. This milestone marks a pivotal… Read More

2 days ago

SEVENTEEN’s MINGYU and VERNON Aren’t the Same After Hong Kong?

Carats, get ready to uncover the mysterious charm that captures the souls of MINGYU and… Read More

2 days ago

Claytan × MuzArt: The Ultimate Collaboration to Unleash Your Full Creative Flair!

MuzArt International teamed up with Claytan Group, Malaysia’s legendary ceramics pioneer, to launch the CPO… Read More

3 days ago

Followme Season 17 Trading Arena Begins! Claim the Global Market Crown Now

Calling for market gladiators now! It’s time to turn your trading confidence into real results… Read More

3 days ago

Lexon x Jeff Koons Bring the Legendary Balloon Dog to Life with Sound, Light, and AR Innovation

Lexon x Jeff Koons Bring the Legendary Balloon Dog to Life with Sound, Light, and… Read More

3 days ago

Skincare on the Go, Dododots’ Mini Pimple Patch Packs Now at Over 2,000 7-Elevens

Getting your favourite Dododots pimple patches just became easier than ever. The Malaysian-born skincare brand… Read More

3 days ago

This website uses cookies.